| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/20/2000 | CA2379034A1 Metabolically engineered microbial cell comprising a modified redox activity |
| 01/20/2000 | CA2337685A1 Modified proteins |
| 01/20/2000 | CA2336710A1 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 01/20/2000 | CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | CA2335272A1 Mouse growth hormone secretagogue receptor |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2333857A1 Growth hormone secretagogue related receptors and nucleic acids |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332346A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 01/20/2000 | CA2332311A1 Disintegrin homologs |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/19/2000 | EP0972844A1 Process for preparing highly unsaturated fatty acid and lipid containing highly unsaturated fatty acid |
| 01/19/2000 | EP0972839A1 Insertional mutations in mycobacteria |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972834A1 Induction promoter gene and secretory signal gene usable in schizosaccharomyces pombe, expression vectors having the same, and use thereof |
| 01/19/2000 | EP0972183A1 Methods for concentrating ligands using magnetic particles |
| 01/19/2000 | EP0972074A1 A method for identifying the site of action of xenobiotic chemicals |
| 01/19/2000 | EP0972068A1 A process for synthesizing oligosaccharides |
| 01/19/2000 | EP0972065A1 Microbial method for producing polyhydroxy alkanoates |
| 01/19/2000 | EP0972062A2 Plant pest control |
| 01/19/2000 | EP0972061A2 Novel uses of male sterility in plants |
| 01/19/2000 | EP0972057A2 Method for screening antimycotically active substances |
| 01/19/2000 | EP0972056A1 Reagents and methods useful for detecting diseases of the lung |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972052A1 Keratinocyte derived kallikrein |
| 01/19/2000 | EP0972051A1 Rna-dependent rna polymerase functioning preferably on rna matrix and promoter-dependent transcription process with said rna-dependent rna polymerase |
| 01/19/2000 | EP0972049A1 Microbial production of 1,2-propanediol from sugar |
| 01/19/2000 | EP0972046A1 METHODS OF PRODUCING AND USING VIRULENCE ATTENUATED $i(poxR) MUTANT BACTERIA |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972044A1 Chemokine beta-6 |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972038A1 Human tumorigenesis associated protein, htap |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972035A1 Human tumor suppressor |
| 01/19/2000 | EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 01/19/2000 | EP0972033A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 01/19/2000 | EP0972030A2 70human secreted proteins |
| 01/19/2000 | EP0972029A1 Human secreted proteins |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972027A1 Human c5a-like receptor |
| 01/19/2000 | EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 01/19/2000 | EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES |
| 01/19/2000 | EP0972022A2 Polynucleotides and polypeptides encoding receptors |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0972011A1 Cyclin-dependent protein kinase |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971734A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | CN1241909A Biological control of plant fungal infections |
| 01/19/2000 | CN1241630A Common wild-rice near isogenic line resisting bacterial leaf-blight and its breeding process |
| 01/18/2000 | US6015938 Osteoprotegerin |
| 01/18/2000 | US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents |
| 01/18/2000 | US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate |
| 01/18/2000 | US6015709 Nucleic acid which encodes a transcription factor including transcription activation domains and a dna binding domain; for high-level expression of a target gene in genetically engineered cells |
| 01/18/2000 | US6015708 Yeast artificial chromosome with mammalian dna including target gene and heterologous regulatory sequence; for expression in a mammalian cell and high yield of product with less manipulation |
| 01/18/2000 | US6015707 Treating cellulosic materials with cellulases from chrysosporium |
| 01/18/2000 | US6015706 Microorganism resistant to hydrogen peroxide |
| 01/18/2000 | US6015705 Method of modifying the DNA of an organism, DNA sequence, method of detection and isolation of a gene capable of modifying the DNA of an organism and organisms comprising modified DNA |
| 01/18/2000 | US6015703 Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase |
| 01/18/2000 | US6015702 Nucleotide and amino acid sequences; for diagnosis, prevention and treatment of neoplastic, developmental, immune and nervous system disorders; anticarcinogenic/antitumor/ antisense agents |
| 01/18/2000 | US6015701 N-acetylglucosaminyltransferase V proteins and coding sequences |
| 01/18/2000 | US6015697 Method for producing nucleoside-5'-phosphate ester |
| 01/18/2000 | US6015696 Mycobacterium bovis bcg that has been transformed with a vector comprising a promoter, a signal sequence, a dna sequence encoding a heterologous polypeptide, and a replicator region; for vaccines |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015691 Nucleotide and amino acid sequences; for diagnosis and treatment of infections; for vaccines |
| 01/18/2000 | US6015688 Transferrin receptor genes |
| 01/18/2000 | US6015685 Ancrod proteins, their preparation and use |
| 01/18/2000 | US6015684 Astaxanthin over-producing strains of Phaffia rhodozyma method for their cultivation and their use in animal feeds |
| 01/18/2000 | US6015677 Assay methods using DNA encoding mammalian phosphodiesterases |
| 01/18/2000 | US6015669 Identification of genes |
| 01/18/2000 | US6015668 Cloned DNA polymerases from thermotoga and mutants thereof |
| 01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
| 01/18/2000 | US6015567 HER2 extracellular domain |
| 01/18/2000 | CA2132954C Modified ciliary neurotrophic factors |
| 01/18/2000 | CA2113871C A strain of streptomyces lavendofoliae dkrs and a method for producing aclacinomycins a,b,y and aglycones using the same |
| 01/18/2000 | CA2087960C Endogenously sweetened transgenic plant products |
| 01/18/2000 | CA2050336C Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
| 01/18/2000 | CA2027977C Arylsulfatase |
| 01/18/2000 | CA2013239C Yeast strains for the production of nature heterolegous proteins, especially hirudine, and corresponding process for the preparation of hirudine |
| 01/18/2000 | CA1340876C The vp7 gene of human rotavirus 4 |
| 01/13/2000 | WO2000001846A2 Characterisation of gene function using double stranded rna inhibition |
| 01/13/2000 | WO2000001840A1 Fermentation process to produce clavulanic acid at a low concentration of free amino acids |
| 01/13/2000 | WO2000001839A1 Improved microbial strains producing sphingoid bases |
| 01/13/2000 | WO2000001829A2 Formaldehyde dehydrogenase genes from methylotrophic yeasts |
| 01/13/2000 | WO2000001827A2 Polyketides, their preparation, and materials for use therein |
| 01/13/2000 | WO2000001818A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | WO2000001817A2 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001812A1 Fungal signal peptide sequences for chitinolytic enzymes and uses thereof |
| 01/13/2000 | WO2000001811A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 01/13/2000 | WO2000001810A1 Novel promoter sequences of myostatin gene |
| 01/13/2000 | WO2000001808A2 IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS) |
| 01/13/2000 | WO2000001803A1 Non-macroporous inorganic support for bioremediation |
| 01/13/2000 | WO2000001801A1 Ftsz multimeric proteins and their uses |
| 01/13/2000 | WO2000001799A2 Method of preventing bacteriophage infection of bacterial cultures |
| 01/13/2000 | WO2000001731A1 Fused protein with direct bond of il-6-receptor to il-6 |